Amplia Therapeutics Shares Rally 17% on Fourth Confirmed Response in Pancreatic Cancer Trial
Amplia Therapeutics Shares Rally 17% on Fourth Confirmed Response in Pancreatic Cancer Trial
Amplia Therapeutics 的股票在胰腺癌试验中第四次获得确认响应后上涨了17%
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册